Companies / Access Bio
Access Bio
United States
Access Bio develops in vitro diagnostics technology and commercializes products to battle diseases such as malaria and COVID-19.
Access Bio, based in United States, has 1 investor on file, among them Global Health Investment Corporation. Its site was last checked 7 Nov 2026: site answers.
SEC Form D filings
3 filingsFiled by ACCESS BIO, INC. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor |
More from Global Health Investment Corporation
22 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (92%), Media & Entertainment (4%), Cybersecurity (4%).
See Global Health Investment Corporation's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Access Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Global Health Investment Corporation adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/accessbio.net/investors
# also
GET /v1/companies/accessbio.net
GET /v1/companies/accessbio.net/news